Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Trial of Oncolytic Measles Virotherapy in Mesothelioma

NCT01503177 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01503177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01503177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Trial of Oncolytic Measles Virotherapy in Mesothelioma
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2011
Completion date
April 11, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent malignant mesothelioma, stage ia malignant mesothelioma, stage ib malignant mesothelioma, stage ii malignant mesothelioma, stage iii malignant mesothelioma, stage iv malignant mesothelioma